Zobrazeno 1 - 10
of 169
pro vyhledávání: ''
Autor:
Emma Hansson, Carl Johan Malm, Anders Jeppsson, Andreas Martinsson, Susanne Nielsen, Erik Björklund, Aldina Pivodic
Publikováno v:
International Journal of Cardiology. 331:40-45
Renin-angiotensin system (RAS) inhibitors are recommended postoperatively to coronary artery bypass grafting (CABG) patients with reduced left ventricular function, diabetes, hypertension or previous myocardial infarction, but not to remaining patien
Autor:
Wesley Yang, S. Burgess, Craig P. Juergens, Tuan V. Nguyen, Melissa Leung, I. Shugman, Kristy P. Robledo, Sidney Lo, H. Idris, John K. French, A. McLean, Liza Thomas, Christian J. Mussap
Publikováno v:
International Journal of Cardiology. 323:13-18
In patients with diabetes mellitus presenting with ST elevation myocardial infarction (STEMI) the degree to which cardiac death rates may be attributed to an increased burden of coronary artery disease is not clear.This prospective observational stud
Autor:
Sandeep Aggarwal, Codie R. Rouleau, Tavis S. Campbell, Stephen B. Wilton, Ross Arena, Deepika Laddu, Cemal Ozemek, Trina Hauer, Leslie D. Austford
Publikováno v:
Int J Cardiol
BACKGROUND: Type 2 diabetes and cardiometabolic comorbidities manifesting as the metabolic syndrome (MetS) are highly prevalent in coronary heart disease (CHD) patients attending cardiac rehabilitation (CR). The study aimed to determine the prevalenc
Autor:
Craig P. Juergens, Samuel Kim, Sidney Lo, Gabriel Andrew Gregory, S. Burgess, Mohamed Eftal bin Mohamed Ebrahim, Waleed Aty, Christian J. Mussap, Rebecca Dignan, Leia Hee, John K. French, Giuseppe Femia
Publikováno v:
International Journal of Cardiology. 296:21-25
The Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multi-Vessel Disease (FREEDOM) clinical trial randomized only a proportion of screened patients with diabetes mellitus (DM) and multi-vessel disease (MV
Autor:
Hiroshi Kajio, Tetsuro Tsujimoto
Publikováno v:
International Journal of Cardiology. 282:1-6
Background This study aimed to assess strategies of insulin-providing (IP) or insulin-sensitizing (IS) therapy for glycemic control in nonobese diabetic patients with coronary artery disease (CAD) with possibly higher cardiovascular risk and lower in
Autor:
Marc-André Körten, Ulrike M M Bauer, Peter Ewert, Paul C. Helm, Helmut Baumgartner, Gerhard-Paul Diller, Oktay Tutarel
Publikováno v:
International Journal of Cardiology. 277:79-84
Background As adult congenital heart disease (ACHD) patients are aging, a high prevalence of cardiovascular risk factors is encountered similar to the general population. Currently, data regarding the primary and secondary prevention of acquired card
Autor:
Ally B. Dinhofer, Hye Gi Shim, Kana Fujikura, Jorge R. Kizer, Sanyog G. Shitole, Bradley Peltzer, Mario J. Garcia, Nidhish Tiwari
Publikováno v:
International Journal of Cardiology. 272:323-328
Background Patients with chronic kidney disease are at increased risk of cardiovascular disease (CVD). Even after kidney transplant, the rate of CVD events and death remain elevated. Early detection of patients at risk would be helpful for guiding ag
Autor:
Ji Min Sung, Eun Ju Chun, Hae Ok Jung, Ji Hyun Lee, Sang Eun Lee, Hae Won Han, Donghee Han, Su Yeon Choi, Sung Hak Park, Jidong Sung, Hyuk Jae Chang, Ki-Bum Won
Publikováno v:
International Journal of Cardiology. 266:250-253
Data on the impact of optimal glycemic control (OGC) on the progression of coronary artery calcification, an important marker for future adverse cardiovascular events in individuals with diabetes are limited.We investigated 1637 asymptomatic adults w
Autor:
Hirmand Nouraei, Simon W. Rabkin
Publikováno v:
International journal of cardiology. 331
Objective Heart failure with preserved ejection (HFpEF) represents nearly half of all patients with heart failure (HF). The objective of this study was to determine whether patient characteristics identify discrete kinds of HFpEF. Methods Data were c
Autor:
Anthony Mathur, Alun D. Hughes, Andrea Comella, Michael Michail, James D. Cameron, Jasmine Chan, Robert Gooley, Adam J. Brown
Publikováno v:
International journal of cardiology. 332
Patients with severe aortic stenosis (AS) exhibit systemic endothelial dysfunction, which can be associated with myocardial ischaemia in absence of obstructive coronary disease. Transcatheter aortic valve replacement (TAVR) is used to treat severe AS